C0730285||Diabetic macular edema
C0042798||vision loss
C0041703||United States
C0162648||Telemedicine
C0220908||screening programs
C0002783||epidemiological studies
C0200189||monoscopic fundus photography
C0730284||clinically significant macular edema
C0730284||clinically significant macular edema
C1511790||detecting
C0730284||clinically significant macular edema
C1704922||monoscopic images
C0920367||optical coherence tomography
C0730285||diabetic macular edema
C1710031||screening test
C1708237||sectors
C0730284||clinically significant macular edema
C0010362||cross-sectional study
C0730284||clinically significant macular edema
C1704922||monoscopic images
C1708237||sectors
C0449445||approach
C0011884||Diabetic Retinopathy
C2603343||Study
C0150312||presence
C0730284||clinically significant macular edema
C0430022||methods
C0200189||stereoscopic fundus photography
C0200189||method 1
C0430022||biomicroscopy
C0920367||optical coherence tomography
C0920367||method 2
C0679646||Participants
C0041740||university
C1319402||practice
C0017446||Area
C0015392||eyes
C1511553||ethnically/racially diverse group
C0043210||female
C0936012||analysis
C0015392||eyes
C0430022||diagnosed
C0730284||clinically significant macular edema
C0200189||method 1
C0730284||clinically significant macular edema
C0430022||diagnosis
C1708237||sector
C0017446||Area
C1708237||sectors
C0449445||approach
C0200189||method 1
C0430022||methods
C1708237||sectors
C0449445||approach
C0920367||method 2
C1708237||sectors
C0449445||approach
C1710031||screening test
C0730284||clinically significant macular edema
C0162648||telemedicine programs
C0449445||approach
C0920367||optical coherence tomography
C0449445||way
C1302690||retinal thickening
C0430022||method
C0011884||diabetic retinopathy
C0002045||algorithms